文献速递角膜与眼表疾病神经眼科

局部阿片受体阻断逆转糖尿病干眼涉及双重通路

Reversal of Diabetic Dry Eye by Topical Opioid Receptor Blockade Follows Dual Pathways.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

研究在1型糖尿病大鼠模型上每日局部滴用纳曲酮15天,发现用药5天内泪液分泌和角膜敏感性恢复至正常水平;15天后角膜OGFr表达、上皮细胞数和Ki67+表达恢复正常,炎症标志物如TNF-α降低,三叉神经节中CGRP阳性神经元比例增加而P物质阳性神经元未增加,雌雄大鼠反应相当。

要点

  • 糖尿病大鼠局部滴用纳曲酮5天内泪液分泌和角膜敏感性恢复至正常水平
  • 纳曲酮治疗15天使角膜OGFr表达、上皮细胞数和Ki67+表达恢复正常并降低TNF-α等炎症标志物
  • 纳曲酮治疗后三叉神经节CGRP阳性神经元比例增加而P物质阳性神经元未增加,雌雄大鼠反应相当

核心结论

  • 1型糖尿病导致泪液分泌减少和角膜表面敏感性改变,这些并发症与维持眼表稳态的OGFr失调同时出现;雌雄糖尿病大鼠局部纳曲酮治疗15天后干眼逆转和角膜敏感性恢复,涉及细胞增殖增加和炎症减少的双重通路。

研究设计与样本

  • 研究将纳曲酮滴眼液每日局部滴用于雄性和雌性成年1型糖尿病大鼠角膜表面,持续15天。
  • 在基线、第5天、第10天和第15天测量Schirmer评分和角膜敏感性。
  • 对角膜和三叉神经节进行免疫组化检测OGFr、Ki67、神经生长因子、胰岛素样生长因子-1、降钙素基因相关肽、P物质和TNF-α的表达。
  • 通过蛋白质组学研究检测角膜中的蛋白质变化。

主要发现

  • 糖尿病大鼠局部纳曲酮治疗后5天内角膜敏感性和泪液分泌恢复至正常水平。
  • 治疗15天后,角膜OGFr表达缺陷、上皮细胞数量缺陷和Ki67+表达缺陷均被纳曲酮恢复至正常。
  • 纳曲酮治疗的糖尿病大鼠组织中炎症标志物(如TNF-α)减少。
  • 蛋白质组学数据提示糖尿病引起炎症生物学过程失调。
  • 纳曲酮治疗后三叉神经节中降钙素基因相关肽阳性神经元百分比增加,而P物质阳性神经元百分比未增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine pathways in the trigeminal ganglion and corneal epithelium that are targeted by topical naltrexone (NTX) treatment for dry eye. METHODS: NTX drops were administered topically daily for 15 days to the corneal surface of male and female adult type 1 diabetic rats. Schirmer scores and corneal sensitivity were measured at baseline, 5, 10, and 15 days. Trigeminal ganglion and corneal epithelium were processed for immunohistochemistry to detect expression of opioid growth factor receptor (OGFr), Ki67, nerve growth factor, insulin-like growth factor-1, calcitonin gene-related peptide, substance P, and TNF-α. A proteomic study determined protein changes in the cornea. RESULTS: Corneal sensitivity and tear production in diabetic rats were restored to normal levels within 5 days after topical NTX. Assessment of corneal tissue after 15 days of treatment revealed that defects in OGFr expression, epithelial cell number, and Ki67+ expression were restored to normal by NTX. Inflammation markers (e.g., TNF-α) were reduced in tissue from diabetic rats treated with NTX. Proteomic data suggest diabetes causes dysregulation in inflammatory biological processes. The percentages of calcitonin gene-related peptide-positive neurons, but not substance P-positive neurons, in the trigeminal ganglion were increased after NTX treatment. Diabetic male and female rats responded to NTX in a comparable manner. CONCLUSIONS: Type 1 diabetes results in decreased tear production and altered corneal surface sensitivity. These complications coincide with dysregulated OGFr that maintains ocular homeostasis. Reversal of dry eye and restoration of corneal sensitivity in diabetic male and female rats after 15 days of topical treatment with NTX occur following dual pathways of increased cellular proliferation and reduction of inflammation.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Diaz D, Sassani JW, Zagon IS, et al. Reversal of Diabetic Dry Eye by Topical Opioid Receptor Blockade Follows Dual Pathways. Invest Ophthalmol Vis Sci. 2025. PMID: 40062813. doi:10.1167/iovs.66.3.24

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。